In PCa patients, their prognostic role remains controversial [15,16] As already pointed out, PCa presents a low immunogenicity with few TILs in the tumor microenvironment (100 CD8+ T cells per mm2) [17,18]. The gene discussed is CD8A; the disease is posterior cortical atrophy.